American Society of Echocardiography (ASE) President Stephen Little, MD, says there will be an increasing need for interventional echocardiographers in the near future.

Researchers examined data from more than 1,300 procedures, presenting their findings in JACC: Cardiovascular Interventions.

New research published in the Canadian Journal of Cardiology represents one the most detailed pictures to date of the long-term impact of ViV TMVR.

Rebecca Hahn, MD, examines the growing role of the dedicated interventional echocardiographer and how these imagers are paid.

“If we can deploy our model on a population-level ECG screening, we would be able to pick up many more of these patients before they have irreversible damage,” a cardiologist behind the new study explained. 

This represents the latest iteration of the Watchman technology, which was first approved by the FDA back in 2020. 

Researchers uncovered new details about how mitral regurgitation can impact one-year TAVR outcomes, sharing their findings in the Journal of the American Heart Association.